SCHEMBL21884067

SCHEMBL21884067

CC1O[C@H](OC2CC[C@@H](O)OC2C)CCC1O

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SAE1 Q9UBE0 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13181985 1.00 SAE1 (0.31) SAE1
SCHEMBL21883695 1.00 SAE1 (0.31) SAE1
SCHEMBL21883707 1.00 SAE1 (0.31) SAE1
SCHEMBL21883847 1.00 SAE1 (0.31) SAE1
SCHEMBL17773085 0.86
SCHEMBL17773079 0.86
SCHEMBL17773087 0.86
SCHEMBL17773081 0.86
SCHEMBL18937993 0.79
SCHEMBL21883846 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10610539-B2 Cardiac glycoside analogs and their use in methods for inhibition of viral infection THE JOHN HOPKINS UNIVERSITY (US) 2020-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10610539-B2 Cardiac glycoside analogs and their use in methods for inhibition of viral infection ATP1A3, ATP1A2, ATP1B3 SAE1 3809/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.